Literature DB >> 9207797

Endothelial apoptosis in Braf-deficient mice.

L Wojnowski1, A M Zimmer, T W Beck, H Hahn, R Bernal, U R Rapp, A Zimmer.   

Abstract

Tyrosine kinase growth factor receptors and Ras/Raf/MEK/MAPK signalling have been implicated in the suppression as well as augmentation of programmed cell death. In addition, a Ras-independent role for Raf as a suppressor of programmed cell death has been suggested by the recent finding that Craf1 interacts with members of the Bcl-2 family at mitochondrial membranes. However, genetic studies of C. elegans and Drosophila, as well as the targeted mutagenesis of the murine Araf gene, have failed to support such a role. Here we show that mice with a targeted disruption in the Braf gene die of vascular defects during mid-gestation. Braf -/- embryos, unlike Araf -/- or Craf1 -/- embryos (L.W. et al., unpublished), show an increased number of endothelial precursor cells, dramatically enlarged blood vessels and apoptotic death of differentiated endothelial cells. These results establish Braf as a critical signalling factor in the formation of the vascular system and provide the first genetic evidence for an essential role of Raf gene in the regulation of programmed cell death.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207797     DOI: 10.1038/ng0797-293

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  84 in total

1.  B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway.

Authors:  P Erhardt; E J Schremser; G M Cooper
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  c-Raf regulates cell survival and retinal ganglion cell morphogenesis during neurogenesis.

Authors:  B Pimentel; C Sanz; I Varela-Nieto; U R Rapp; F De Pablo; E J de La Rosa
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 3.  Opioid receptor trafficking and signaling: what happens after opioid receptor activation?

Authors:  Jia-Ming Bian; Ning Wu; Rui-Bin Su; Jin Li
Journal:  Cell Mol Neurobiol       Date:  2011-09-25       Impact factor: 5.046

4.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

Review 5.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors:  Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal:  Mol Carcinog       Date:  2010-07-20       Impact factor: 4.784

Review 6.  MAP kinase pathways: the first twenty years.

Authors:  Joseph Avruch
Journal:  Biochim Biophys Acta       Date:  2006-11-15

7.  Cortical migration defects in mice expressing A-RAF from the B-RAF locus.

Authors:  Guadalupe Camarero; Oleg Yu Tyrsin; Chaomei Xiang; Verena Pfeiffer; Sandra Pleiser; Stefan Wiese; Rudolf Götz; Ulf R Rapp
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

8.  BRAF inactivation drives aneuploidy by deregulating CRAF.

Authors:  Tamihiro Kamata; Jahan Hussain; Susan Giblett; Robert Hayward; Richard Marais; Catrin Pritchard
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

9.  Essential role of B-Raf in ERK activation during extraembryonic development.

Authors:  Gergana Galabova-Kovacs; Dana Matzen; Daniela Piazzolla; Katrin Meissl; Tatiana Plyushch; Adele P Chen; Alcino Silva; Manuela Baccarini
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 10.  Kinase mutations in human disease: interpreting genotype-phenotype relationships.

Authors:  Piya Lahiry; Ali Torkamani; Nicholas J Schork; Robert A Hegele
Journal:  Nat Rev Genet       Date:  2010-01       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.